Skip to main content

Advertisement

Log in

Changes in brain white matter integrity after systemic treatment for breast cancer: a prospective longitudinal study

  • Original Research
  • Published:
Brain Imaging and Behavior Aims and scope Submit manuscript

Abstract

An increasing number of studies suggest chemotherapy for breast cancer may be neurotoxic. Cross-sectional MRI diffusion tensor imaging (DTI) studies suggest a vulnerability of brain white matter to various chemotherapeutic regimens. Up till now, this was confirmed in one prospective DTI study: Deprez et al. (2012) showed a widespread decline in fractional anisotropy (FA) of breast cancer patients after chemotherapy consisting of 5-fluorouracil (5-FU), epirubicin and cyclophosphamide (FEC) +/− taxanes +/− endocrine treatment. Our aim was to evaluate whether similar detrimental effects on white matter integrity would be observed with the currently widely prescribed anthracycline-based chemotherapy for breast cancer (predominantly doxorubicin and cyclophosphamide +/− taxanes +/− endocrine treatment (=BC + SYST; n = 26) compared to no systemic treatment (BC; n = 23) and no-cancer controls (NC; n = 30). Assessment took place before and six months after chemotherapy, and matched intervals for the unexposed groups. DTI data were analyzed using voxel-based tract-based spatial statistics and region of interest (ROI) analysis. Voxel-based analysis did not show an effect of chemotherapy +/− endocrine treatment on white matter integrity. ROI analysis however indicated subtle detrimental effects of chemotherapy +/− endocrine treatment by showing a larger decline in WM integrity in the superior longitudinal fasciculus and corticospinal tract in BC + SYST than BC. Indications for relatively mild neurotoxicity in our study might be explained by patient characteristics and specific aspects of data analysis. The omission of 5-FU in current treatment regimens or the administration of doxorubicin instead of epirubicin is also discussed as an explanation for the observed effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European Organization for Research and Treatment of cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85, 365–376. doi:10.1093/jnci/85.5.365.

    Article  CAS  PubMed  Google Scholar 

  • Abraham, J., Haut, M. W., Moran, M. T., Filburn, S., Lemiuex, S., & Kuwabara, H. (2008a). Adjuvant chemotherapy for breast cancer: Effects on cerebral white matter seen in diffusion tensor imaging. Clinical Breast Cancer, 8(1), 88–91. doi:10.3816/CBC.2008.n.007.

    Article  PubMed  Google Scholar 

  • Abraham, J., Haut, M. W., Moran, M. T., Filburn, S., Lemiuex, S., & Kuwabara, H. (2008b). Adjuvant chemotherapy for breast cancer: Effects on cerebral white matter seen in diffusion tensor imaging. Clinical Breast Cancer, 8(1), 88–91.

    Article  PubMed  Google Scholar 

  • Akitake, R., Miyamoto, S., Nakamura, F., Horimatsu, T., Ezoe, Y., Muto, M., & Chiba, T. (2011). Early detection of 5-FU-induced acute leukoencephalopathy on diffusion-weighted MRI. Japanese Journal of Clinical Oncology, 41(1), 121–124. doi:10.1093/jjco/hyq157.

    Article  PubMed  Google Scholar 

  • Alpherts, W., Aldenkamp, A. P. (1994). FePsy: The iron psyche. Heemstede.

  • Assaf, Y., & Pasternak, O. (2008). Diffusion tensor imaging (DTI)-based white matter mapping in brain research: A review. Journal of molecular neuroscience : MN, 34(1), 51–61. doi:10.1007/s12031-007-0029-0.

    Article  CAS  PubMed  Google Scholar 

  • Bach, M., Laun, F. B., Leemans, A., Tax, C. M. W., Biessels, G. J., Stieltjes, B., & Maier-Hein, K. H. (2014). Methodological considerations on tract-based spatial statistics (TBSS). NeuroImage, 100, 358–369. doi:10.1016/j.neuroimage.2014.06.021.

    Article  PubMed  Google Scholar 

  • Barrick, T. R., Charlton, R. A., Clark, C. A., & Markus, H. S. (2010). White matter structural decline in normal ageing: A prospective longitudinal study using tract-based spatial statistics. NeuroImage, 51(2), 565–577. doi:10.1016/j.neuroimage.2010.02.033.

    Article  PubMed  Google Scholar 

  • Benedict, R. H. B., Schretlen, D., Groninger, L., & Brandt, J. (1998). Hopkins verbal learning test – Revised: Normative data and analysis of inter-form and test-retest reliability. The Clinical Neuropsychologist, 12, 43–55. doi:10.1076/clin.12.1.43.1726.

    Article  Google Scholar 

  • Briones, T. L., & Woods, J. (2014). Dysregulation in myelination mediated by persistent neuroinflammation: Possible mechanisms in chemotherapy-related cognitive impairment. Brain, Behavior, and Immunity, 35, 23–32. doi:10.1016/j.bbi.2013.07.175.

    Article  CAS  PubMed  Google Scholar 

  • Cheung, Y. T., Lim, S. R., Ho, H. K., & Chan, A. (2013). Cytokines as mediators of chemotherapy-associated cognitive changes: Current evidence, limitations and directions for future research. PloS One, 8(12). doi:10.1371/journal.pone.0081234.

  • Choi, S. M., Lee, S. H., Yang, Y. S., Kim, B. C., Kim, M. K., & Cho, K. H. (2001). 5-fluorouracil-induced leukoencephalopathy in patients with breast cancer. Journal of Korean Medical Science. doi:10.3346/jkms.2001.16.3.328.

    Google Scholar 

  • Cohen, S., Kamarck, T., & Mermelstein, R. (1983). A global measure of perceived stress. Journal of Health and Social Behavior, 24(4), 385–396.

    Article  CAS  PubMed  Google Scholar 

  • De Ruiter, M. B., Reneman, L., Boogerd, W., Veltman, D. J., Caan, M., Douaud, G., et al. (2012). Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging. Human Brain Mapping, 33(12), 2971–2983. doi:10.1002/hbm.21422.

    Article  PubMed  Google Scholar 

  • Dekkers, A. M. M., Olff, M., & Näring, G. W. B. (2010). Identifying persons at risk for PTSD after trauma with TSQ in the Netherlands. Community Mental Health Journal, 46(1), 20–25. doi:10.1007/s10597-009-9195-6.

    Article  CAS  PubMed  Google Scholar 

  • Deprez, S., Amant, F., Yigit, R., Porke, K., Verhoeven, J., Van den Stock, J., et al. (2011). Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients. Human Brain Mapping, 32(3), 480–493. doi:10.1002/hbm.21033.

    Article  PubMed  Google Scholar 

  • Deprez, S., Amant, F., Smeets, A., Peeters, R., Leemans, A., Van Hecke, W., et al. (2012). Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. Journal of Clinical Oncology, 30(3), 274–281. doi:10.1200/JCO.2011.36.8571.

  • Eriksen, B. A., & Eriksen, C. W. (1974). Effects of noise letters upon the identification of a target letter in a nonsearch task. Perception & Psychophysics. doi:10.3758/BF03203267.

    Google Scholar 

  • Fan, Y., Lin, K., Liu, H., Chen, Y., & Wu, C. (2015). Changes in structural integrity are correlated with motor and functional recovery after post-stroke rehabilitation. Restorative Neurology and Neuroscience, 33(6), 835–844. doi:10.3233/RNN-150523.

    Article  PubMed  Google Scholar 

  • Fazekas, F., Chawluk, J. B., Alavi, A., Hurtig, H. I., & Zimmerman, R. A. (1987). MR signal abnormalities at 1. 5 T in Alzheimer ’ s dementia and normal aging deficiency. AJNR. American Journal of Neuroradiology, 149(August), 351–356. doi:10.2214/ajr.149.2.351.

    CAS  Google Scholar 

  • Gosling, S. D., Rentfrow, P. J., & Swann, W. B. (2003). A very brief measure of the big-five personality domains. Journal of Research in Personality, 37, 504–528. doi:10.1016/S0092-6566(03)00046-1.

    Article  Google Scholar 

  • Han, R., Yang, Y. M., Dietrich, J., Luebke, A., Mayer-Pröschel, M., & Noble, M. (2008). Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system. Journal of Biology, 7(4), 12. doi:10.1186/jbiol69.

    Article  PubMed  PubMed Central  Google Scholar 

  • Hesbacher, P. T., Rickels, K., Morris, R. J., Newman, H., & Rosenfeld, H. (1980). Psychiatric illness in family practice. The Journal of Clinical Psychiatry, 41(1), 6–10.

    CAS  PubMed  Google Scholar 

  • Israel, Z. H., Lossos, A., Barak, V., Soffer, D., & Siegal, T. (2000). Multifocal demyelinative leukoencephalopathy associated with 5-fluorouracil and levamisole. Acta Oncologica, 39(1), 117–120.

  • Khasraw, M., Bell, R., & Dang, C. (2012). Epirubicin: Is it like doxorubicin in breast cancer? A clinical review. Breast, 21(2), 142–149. doi:10.1016/j.breast.2011.12.012.

    Article  PubMed  Google Scholar 

  • Koppelmans, V., de Groot, M., de Ruiter, M. B., Boogerd, W., Seynaeve, C., Vernooij, M. W., et al. (2014). Global and focal white matter integrity in breast cancer survivors 20 years after adjuvant chemotherapy. Human Brain Mapping, 35(3), 889–899. doi:10.1002/hbm.22221.

    Article  PubMed  Google Scholar 

  • Mangin, J.-F., Poupon, C., Clark, C., Le Bihan, D., & Bloch, I. (2002). Distortion correction and robust tensor estimation for MR diffusion imaging. Medical Image Analysis, 6(3), 191–198.

    Article  PubMed  Google Scholar 

  • McDonald, B. C., Conroy, S. K., Ahles, T. A., West, J. D., & Saykin, A. J. (2010). Gray matter reduction associated with systemic chemotherapy for breast cancer: A prospective MRI study. Breast Cancer Research and Treatment, 123(3), 819–828. doi:10.1007/s10549-010-1088-4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Menning, S., de Ruiter, M., Veltman, D., Koppelmans, V., Kirschbaum, C., Boogerd, W., et al. (2015). Multimodal MRI and cognitive function in patients with breast cancer prior to adjuvant treatment - the role of fatigue. NeuroImage: Clinical, 7, 547–554.

    Article  Google Scholar 

  • Menning, S., de Ruiter, M. B., & Kieffer, J. M. Agelink van Rentergem, J., Veltman, D. J., Fruijtier, A., et al. (2016). Cognitive Impairment in a Subset of Breast Cancer Patients After Systemic Therapy - Results From a Longitudinal Study. Journal of Pain and Symptom Management, 52(4), 560–569.e1. doi:10.1016/j.jpainsymman.2016.04.012.

  • Nichols, T. E., & Holmes, A. P. (2002). Nonparametric permutation tests for functional neuroimaging: A primer with examples. Human Brain Mapping, 15(1), 1–25.

    Article  PubMed  Google Scholar 

  • Pfefferbaum, A., Rosenbloom, M. J., Chu, W., Sassoon, S. A., Rohlfing, T., Pohl, K. M., et al. (2014). White matter microstructural recovery with abstinence and decline with relapse in alcohol dependence interacts with normal ageing: A controlled longitudinal DTI study. The Lancet. Psychiatry, 1(3), 202–212. doi:10.1016/S2215-0366(14)70301-3.

    Article  PubMed  PubMed Central  Google Scholar 

  • Pierpaoli, C., & Basser, P. J. (1996). Toward a quantitative assessment of diffusion anisotropy. Magnetic Resonance in Medicine, 36(6), 893–906. doi:10.1002/mrm.1910360612.

    Article  CAS  PubMed  Google Scholar 

  • Pomykala, K. L., de Ruiter, M. B., Deprez, S., McDonald, B. C., & Silverman, D. H. S. (2013). Integrating imaging findings in evaluating the post-chemotherapy brain. Brain Imaging and Behavior, 7(4), 436–452. doi:10.1007/s11682-013-9239-y.

    Article  CAS  PubMed  Google Scholar 

  • Schilder, C. M., Seynaeve, C., Beex, L. V., Boogerd, W., Linn, S. C., Gundy, C. M., et al. (2010a). Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: Results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial. Journal of Clinical Oncology, 28(8), 1294–1300. doi:10.1200/JCO.2008.21.3553.

    Article  CAS  PubMed  Google Scholar 

  • Schilder, C. M. T., Seynaeve, C., Linn, S. C., Boogerd, W., Beex, LVAM., Gundy, C. M., et al. (2010b). Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors. Critical Reviews in Oncology/Hematology, 76(2), 133–141. doi:10.1016/j.critrevonc.2009.11.001

  • Schmand, B., Lindeboom, J., & van Harskamp, F. (1992). De Nederlandse Leestest Voor Volwassenen. Lisse: Swets & Zeitlinger.

    Google Scholar 

  • Schwarz, C. G., Reid, R. I., Gunter, J. L., Senjem, M. L., Przybelski, S. A., Zuk, S. M., et al. (2014). Improved DTI registration allows voxel-based analysis that outperforms tract-based spatial statistics. NeuroImage, 94, 65–78. doi:10.1016/j.neuroimage.2014.03.026.

    Article  PubMed  PubMed Central  Google Scholar 

  • Seigers, R., Loos, M., Van Tellingen, O., Boogerd, W., Smit, A. B., & Schagen, S. B. (2015). Cognitive impact of cytotoxic agents in mice. Psychopharmacology, 232(1), 17–37. doi:10.1007/s00213-014-3636-9.

    Article  CAS  PubMed  Google Scholar 

  • Smith, S. M., Jenkinson, M., Johansen-Berg, H., Rueckert, D., Nichols, T. E., Mackay, C. E., et al. (2006). Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data. NeuroImage, 31(4), 1487–1505. doi:10.1016/j.neuroimage.2006.02.024.

    Article  PubMed  Google Scholar 

  • Stewart, A. L., Ware, J. E., Sherbourne, C. D., & Wells, K. B. (1992). Psychological distress/well-being and cognitive functioning measures. In A. L. Stewart & J. E. Ware (Eds.), Measuring functioning and well-being: The medical outcomes study approach (pp. 102–142). Durham, NC: Duke University Press.

    Chapter  Google Scholar 

  • Stouten-Kemperman, M. M., de Ruiter, M. B., Koppelmans, V., Boogerd, W., Reneman, L., & Schagen, S. B. (2014). Neurotoxicity in breast cancer survivors ≥10 years post-treatment is dependent on treatment type. Brain Imaging and Behavior, 275–284. doi:10.1007/s11682-014-9305-0.

  • Sullivan, E. V., Rohlfing, T., & Pfefferbaum, A. (2010). Longitudinal study of callosal microstructure in the normal adult aging brain using quantitative DTI fiber tracking. Developmental Neuropsychology, 35(3), 233–256. doi:10.1080/87565641003689556.

    Article  PubMed  PubMed Central  Google Scholar 

  • Wald, F. D. M., & Mellenbergh, G. J. (1990). De verkorte versie van de Nederlandse vertaling van de Profile of Mood States (POMS). Nederlands Tijdschrift voor de Psychologie, 45, 86–90.

    Google Scholar 

  • Wechsler, D. (2000). WAIS-III Nederlandstalige bewerking. Technische Handleiding. Lisse: Swets & Zeitlinger.

    Google Scholar 

  • Wefel, J. S., Kesler, S. R., Noll, K. R., & Schagen, S. B. (2015). Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults. CA: A Cancer Journal for Clinicians, 65(2), 123–138. doi:10.3322/caac.21258.

    Google Scholar 

  • Weiss, D., & Marmar, C. (1997). The impact of event scale - revised. In J. Wilson & T. Keane (Eds.), Assessing psychological trauma and PTSD (pp. 399–411). New York: Guilford Press.

    Google Scholar 

  • Weng, Q., Tan, B., Wang, J., Wang, J., Zhou, H., Shi, J., et al. (2014). 5-fluorouracil causes severe CNS demyelination by disruption of TCF7L2/HDAC1/HDAC2 complex in adolescent mice. Toxicology, 325, 144–150. doi:10.1016/j.tox.2014.08.011.

    Article  CAS  PubMed  Google Scholar 

  • Winocur, G., Vardy, J., Binns, M. A., Kerr, L., & Tannock, I. (2006). The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice. Pharmacology Biochemistry and Behavior, 85(1), 66–75. doi:10.1016/j.pbb.2006.07.010.

    Article  CAS  Google Scholar 

  • Zwart, W., Terra, H., Linn, S. C., & Schagen, S. B. (2015). Cognitive effects of endocrine therapy for breast cancer: Keep calm and carry on? Nature reviews. Clinical Oncology, 12(10), 597–606. doi:10.1038/nrclinonc.2015.124.

    PubMed  Google Scholar 

Download references

Acknowledgements

This study was funded by the Dutch Cancer Society (KWF 2009-4284). We thank Epie Boven, MD, PhD, Suzan van der Meij, MD, Vera Lustig, MD, and Monique Bos, MD, PhD, for their contributions to the patient recruitment. We are indebted to all patients and controls, as well as physicians and nurses of the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, VU University Medical Center, Flevoziekenhuis, Reinier de Graaf Gasthuis and Academic Medical Center, for providing patients for this study and the research assistants for helping collecting the data.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sanne B. Schagen.

Ethics declarations

Funding

This study was funded by the Dutch Cancer Society (grant number KWF 2009–4284).

Conflict of interest

Author Menning declares that she has no conflict of interest. Author de Ruiter declares that he has no conflict of interest. Author Veltman declares that he has no conflict of interest. Author Boogerd declares that he has no conflict of interest. Author Oldenburg declares that she has no conflict of interest. Author Reneman declares that she has no conflict of interest. Author Schagen declares that she has no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Menning, S., de Ruiter, M.B., Veltman, D.J. et al. Changes in brain white matter integrity after systemic treatment for breast cancer: a prospective longitudinal study. Brain Imaging and Behavior 12, 324–334 (2018). https://doi.org/10.1007/s11682-017-9695-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11682-017-9695-x

Keywords

Navigation